Anonymous ID: c40f6c Dec. 25, 2021, 11:11 p.m. No.117351   🗄️.is 🔗kun   >>7371 >>7473 >>7485

Video: Drone Has Ability to Take Down Illegal Aliens Crossing Border by Shooting Taser Out of It

Drones with TASERS

https://www.thegatewaypundit.com/2021/12/video-drone-ability-take-illegal-aliens-crossing-border-shooting-taser/

 

Does the adage “Guns don’t kill people, people kill people” apply to high tech?

 

Blake Resnick, CEO of BRINC, a company in the chase to sell drones to police, has developed a drone equipped with stun guns, according to The Intercept. Resnick is a 21-year-old entrepreneur who recently received $25 million in venture capital from Silicon Valley investors. Resnick was recently inducted into Forbes’ “30 under 30” list and is a recipient of a Thiel Fellowship.

 

Resnick appears to be an impressive young man.

 

According to The Intercept, Resnick told Stuart Varney of Fox Business his company’s drones are now helping police defuse dangerous hostage situations on a near-daily basis. In the interview, Resnick repeated the claim that he created the company “in large part” as a response to the 2017 Las Vegas massacre. Resnick wanted to help law enforcement to save lives with nonviolent robots equipped with artificial intelligence.

 

Resnick looks to be a rising star in the world of high tech. According to BRINC’s Values and Ethics page, the company will “Never build technologies designed to hurt or kill.” This falls in line with its commitment to “save lives” and its promise not to “build dystopia.”

 

Resnick may be dreaming of a highway to heaven but could the road he is paving lead to hell?

 

BRINC faced backlash when a 2018 promotional video showed that a “Wall of Drones” would be used to “attack migrants crossing the U.S.-Mexico border.”

 

Blake Resnick claims that Brinc was founded “in large part” as a lifesaving response to the 2017 Las Vegas mass shooting. But a company promo video reveals a different vision: selling Taser-armed drones to attack migrants crossing the U.S.-Mexico border. https://t.co/ZMBfDb8sqH pic.twitter.com/k3pnN2uubA

 

— The Intercept (@theintercept) December 14, 2021

 

Three years later, Resnick told The Interceptor in emails that the promotional video for the drones “is immature, deeply regrettable and not at all representative of the direction I have taken the company in since.” The Wall of Drones, Resnick said, was “never fully developed, sold, or used operationally.” The program was discontinued in 2018 because it is “prone to disastrous misuse.”

 

Well said, Mr. Resnick. The notion “with great power comes great responsibility,” dates back at least to the parable of the sword of Damocles, popularized by Roman politician and philosopher Cicero in 45 B.C.

 

The sword was given to Damocles by powerful King Dionysius who was sick with worry over being assassinated. Dionysius, you see, kept order in his kingdom by the use of an iron fist. Damocles thought he was flattering Dionysius one day when he told him how blissful his life must be as king.

 

Irritated, Dionysius invited Damocles to trade places. Damocles accepted and took a seat on the king’s golden couch. Damocles was just getting used to being fed succulent meats by servants when he noticed a razor-sharp sword hanging over his head. The sword was attached to the ceiling by a single horsehair.

 

Fast forward to 1961. In a speech to the United Nations, then-President John F. Kennedy said, “Every man, woman and child lives under a nuclear sword of Damocles, hanging by the slenderest of threads, capable of being cut at any moment by accident or miscalculation or by madness.”

 

For Kennedy, the sword of Damocles was technology itself, nuclear bombs. The idea that technology can solve all of our problems is like the golden couch upon which Damocles sat. It is comfortable. It feels safe. But it’s not.

 

Take heed, young Mr. Resnick. The nuclear bombs weren’t yet equipped with AI.

 

Transhumanism has been defined as “the science of improving the human population through technologies like genetic engineering and artificial intelligence.” Jeffery Epstein, alleged sex-trafficker par excellence, was a big believer in transhumanism, according to The New York Times. Epstein wasn’t planning on using technology to save the world from itself. He was planning on having the world for himself. And his appetite, apparently, was insatiable.

 

AI, whether it is used to enforce the law or enhance human intelligence, will not impact human morality. Humans haven’t progressed much on that account, and we’ve produced a lot of technology since inventing the wheel.

Anonymous ID: c40f6c Dec. 26, 2021, 2:24 a.m. No.117369   🗄️.is 🔗kun   >>7371 >>7379 >>7382 >>7473 >>7485

Paralyzed man with brain chip posts ‘first direct-thought’ tweet

 

https://www.rt.com/news/544428-tweet-thought-brain-implant/

 

A company that implants neural computer interfaces into the brain says a patient with a nervous system disease that left him motionless was able to share a post on social media by just thinking it.

 

A 62-year-old man in Australia diagnosed with amyotrophic lateral sclerosis (ALS) – a disease that causes paralysis – is now able to communicate thoughts with others with no muscle activity involved. On Thursday, he published a post on social media “using only direct thought,” the company that enabled him to do so, Synchron, announced.

 

“I created this tweet just by thinking it” – the tweet read, said to be posted by Philip O’Keefe to the account of Synchron CEO Thomas Oxley.

 

The ‘first direct-thought tweet’ was created wirelessly from O’Keefe’s brain, according to the company. Following progressive paralysis caused by ALS, the man had a brain computer interface called ‘Stentrode’ installed last year. The implant, “designed to enable patients to wirelessly control digital devices through thought,” was inserted via the jugular vein to avoid drilling into the skull.

 

https://twitter.com/tomoxl/status/1473809025254846467

 

“Now, I just think about where on the computer I want to click, and I can email, bank, shop, and now message the world via Twitter,” the company cited O’Keefe as saying – or thinking. According to him, the “astonishing” system takes practice, just like learning to ride a bike, “but once you’re rolling, it becomes natural.”

 

The man, despite debilitating paralysis, is now able to engage in independent activities and reconnect with the world, Synchron claims, adding that it plans to further develop its brain computer interface in an in-human study in the US next year.

Anonymous ID: c40f6c Dec. 26, 2021, 7:55 a.m. No.117379   🗄️.is 🔗kun   >>7380 >>7381 >>7386 >>7415 >>7473 >>7485

>>117371

>>117369

> (could use a DIG)

 

Weird just watched Johnny Mnemonic again recently too

 

Our story

https://synchron.com/about-us

Innovating an Industry

 

Since 2012, we have been developing a solution that avoids the need for open brain surgery by using a minimally-invasive procedure.

 

Quick facts about us

 

The device, the stentrode™, is 8mm in diameter and made from a flexible alloy called nitinol. It is inserted into Superior Sagittal Sinus in the brain via the jugular vein.

Initial grant funding was provided to a lab in the University of Melbourne by the U.S. Defense Advanced Research Projects Agency (DARPA) and Department of Defense (DoD).

In 2020, FDA awarded the stentrode™ the Breakthrough Device Designation. In 2021, Synchron became the first company to receive FDA approval for an IDE to conduct trials of a permanently implantable BCI.

Series B funding was led by Khosla Ventures, with total capital raised now of $70M, including support from the U.S. and Australian governments.

Synchron is headquartered in Brooklyn, New York, and has an office in Melbourne, Australia.

 

The Team

 

We’re a global team of scientists, innovators, and future-thinkers.

 

Tom Oxley CEO

Nick Opie CTO

Amos Meltzer CLO Chief Legal Officer

J Mocco Chief Medical Officer <<--

Gary Castro VP Finance

Riki Banerjee VP RD

Edward Karst Senior Director of Clinical Regulatory

Chloe Brown Director of Marketing

Gil Rind Director of Advanced Technologies

Peter Yoo Director of Neuroscience <<--

Darragh Mc Dermott Director of Hardware

Amanda Zwarenstein Director of Product 1

 

Partners

 

Khosla Ventures

Neuro Technology Investors

Metis Innovative

 

Published Work

https://synchron.com/research

International peer-reviewed scientific publications authored by scientists and engineers at Synchron.

 

Motor neuroprosthesis implanted with neurointerventional surgery improves capacity for activities of daily living tasks in severe paralysis: first in-human experience

Oxley TJ, et al. J NeuroIntervent Surg 2020;0:1–7. doi:10.1136/neurintsurg-2020-016862

https://jnis.bmj.com/content/13/2/102.info

 

Removing the need for invasive brain surgery: the potential of stent electrodes

Opie NL and Oxley TJ. Future Medicine. vol. 2(1), editorial.

https://www.futuremedicine.com/doi/abs/10.2217/bem-2019-0013?journalCode=bem

 

Neural Stimulation with an Endovascular Brain-Machine Interface

Opie NL, John SE, Gerboni G, Rind GS, Lovell TJ, Ronayne SM, et al. 9th International IEEE/EMBS Conference on Neural Engineering (NER), pp. 738-741.

https://ieeexplore.ieee.org/document/8717066

 

...much moar... 2016-2021

 

In the news

https://synchron.com/news

 

America's Greatest Disruptors: Medical Marvels

https://www.newsweek.com/2021/12/24/americas-greatest-disruptors-medical-marvels-1659061.html

 

Next Big Things in Tech 2021

https://www.fastcompany.com/next-big-things-in-tech

 

2022 Dr John Raftos AM Award Winner: Prof Nicholas Opie

https://nfmri.org.au/research-and-innovation/dr-john-raftos-medal/

 

THE BEST INVENTIONS OF 2021

https://time.com/collection/best-inventions-2021/

 

‘Our notion of privacy will be useless’: what happens if technology learns to read our minds?

https://amp.theguardian.com/technology/2021/nov/07/our-notion-of-privacy-will-be-useless-what-happens-if-technology-learns-to-read-our-minds

 

NIH backs Synchron Brain Computer Interface with $10M grant to launch first U.S. clinical trialPDF

https://drive.google.com/uc?export=download&id=1botWAtw3e4hXAZglpJm2up7S5b9EWGwJ

 

Ability to Conduct Human Trials Gives Synchron the Edge in BCI Market

https://www.mddionline.com/implants/ability-conduct-human-trials-gives-synchron-edge-bci-market

 

How a Small Neurotech Startup Beat Elon Musk’s Neuralink to Human Studies

https://futurism.com/neoscope/neurotech-startup-beat-elon-musk-neuralink-fda-approval

 

RELATED

Human brain chip pending FDA approval, Musk says

https://www.rt.com/usa/542505-musk-neuralink-human-testing/

Anonymous ID: c40f6c Dec. 26, 2021, 8:12 a.m. No.117380   🗄️.is 🔗kun   >>7473 >>7485

>>117379

>J Mocco Chief Medical Officer <<--

J Mocco, MD Neurosurgery Mount Sinai Doctors

https://www.mountsinai.org/profiles/j-mocco

 

J Mocco, MD, MS, is a cerebrovascular and endovascular neurosurgeon with clinical interests in stroke, brain aneurysms, subarachnoid hemorrhage, arteriovenous malformations, cavernous malformations, carotid artery stenosis, intracranial stenosis, and brain tumors. He serves as a Professor and Senior System Vice Chair in the Department of Neurosurgery at Mount Sinai, as well as Director of the Cerebrovascular Center. Dr. Mocco was previously Associate Professor of Neurological Surgery, Radiology, and Radiological Sciences at Vanderbilt University Medical Center.

 

Dr. Mocco received his medical degree from the Columbia University College of Physicians & Surgeons. He completed his Master of Science in Biostatistics from the Mailman School of Public Health at Columbia University, a residency in Neurological Surgery from the Neurological Institute of New York, and a fellowship in Endovascular Neurosurgery from the University of Buffalo.

 

Dr. Mocco has published more than 525 peer-reviewed publications, edited three texbooks on neurosurgical techniques, and runs numerous national and international clinical trials to improve the treatment of patients with cerebrovascular disease.

 

Dr. Mocco’s research interests focus on translational efforts to treat ischemic and hemorrhagic stroke.

 

Certification

 

Neurological Surgery

Clinical Focus

 

Acoustic Neuroma

Acoustic Neuroma Removal

Aneurysm Coiling

Arnold-Chiari Syndrome

Arteriovenous Malformations

Astrocytoma

Atherosclerosis

Biopsy

Brain Aneurysm

Brain Metastasis

Brain Tumor And Brain Cancer

Brain, Spine Tumors

Carotid Artery Stenosis

Carotid Stenting

Cavernous Malformations

Chiari Malformation

Craniotomy

Endovascular Embolization

Facial Arteriovenous Malformations

 

Facial Vascular Malformations

Hemangioma

Hemifacial Spasm

Intracerebral Hemorrhage (ICH)

Lymphatic Malformations

Mechanical Thrombectomy

Meningioma

Microvascular Clipping

Microvascular Occlusion

Neuroendoscopy

Sclerotherapy

Spinal Vascular Malformations

Stereotactic Radiosurgery

Stroke

Subarachnoid Hemorrhage

Transient Ischemic Attack

Vascular Malformations

 

Research Topics

 

Angiogenesis, Atherosclerosis, Blood-Brain Barrier, Brain, Brain Imaging, Endothelial Cells, Inflammation, Migration, Neuroscience, Stem Cells, Stroke, Transgenic Mice, Vascular Development

Education

 

MD, Columbia University College of Physicians & Surgeons

 

Residency, Internal Medicine

New York Presbyterian-Columbia University Medical Center

 

Residency, Neurological Surgery

Neurological Institute

 

Fellowship, Neurovascular

University at Buffalo

 

Awards

2018

Top Doctors

NY Magazine

 

2017

Top Doctors - New York Metro Area

Castle Connolly

 

Publications

https://plu.mx/mtsinai/u/mtsinai-jayduffy-mocco

Anonymous ID: c40f6c Dec. 26, 2021, 8:21 a.m. No.117381   🗄️.is 🔗kun   >>7387 >>7473 >>7485

>>117379

>Peter Yoo Director of Neuroscience <<--

Peter Yoo Director of Neuroscience, Synchron

Brain Computer Interface

Neuroprosthesis

fMRI

Machine Learning

 

https://scholar.google.com.au/citations?user=dtbYWxcAAAAJ

 

Focal stimulation of the sheep motor cortex with a chronically implanted minimally invasive electrode array mounted on an endovascular stent

https://scholar.google.com.au/citations?view_op=view_citation&hl=en&user=dtbYWxcAAAAJ&alert_preview_top_rm=2&citation_for_view=dtbYWxcAAAAJ:zYLM7Y9cAGgC

 

Direct electrical stimulation of the brain can alleviate symptoms associated with Parkinson’s disease, depression, epilepsy and other neurological disorders. However, access to the brain requires invasive procedures, such as the removal of a portion of the skull or the drilling of a burr hole. Also, electrode implantation into tissue can cause inflammatory tissue responses and brain trauma, and lead to device failure. Here, we report the development and application of a chronically implanted platinum electrode array mounted on a nitinol endovascular stent for the localized stimulation of cortical tissue from within a blood vessel. Following percutaneous angiographic implantation of the device in sheep, we observed stimulation-induced responses of the facial muscles and limbs of the animals, similar to those evoked by electrodes implanted via invasive surgery. Proximity of the electrode to the motor cortex, yet not its …

Anonymous ID: c40f6c Dec. 26, 2021, 8:29 a.m. No.117382   🗄️.is 🔗kun   >>7383 >>7473 >>7485

>>117369

>>117371

Synchron

Syn Chron

Sin Time

 

Also has an office in Chinafornia

https://www.zoominfo.com/c/synchron/397959100

 

Description

 

Synchron, Inc. is a neurovascular bioelectronics medicine company developing bloodstream-enabled solutions for previously-untreatable nervous system conditions.... Read More

 

Headquarters:

1999 S Bascom Ave, Ste 707, Campbell, California, 95008, United States

 

Phone:

(917) 216-0774

 

Website:

https://www.synchronmed.com

 

Employees:

<25

 

Revenue:

<$5 Million

 

SIC Code 38,384

NAICS Code 339,339112

Anonymous ID: c40f6c Dec. 26, 2021, 8:41 a.m. No.117383   🗄️.is 🔗kun   >>7473 >>7485

>>117382

>>117371

>Tom Oxley CEO

Thomas J Oxley, MD, PhD

https://www.mountsinai.org/profiles/thomas-j-oxley

 

Thomas J. Oxley, MD, PhD, is an instructor and Director of Innovation Strategy for the Department of Neurosurgery at the Mount Sinai Health System. As part of the Cerebrovascular Center, he specializes in vascular neurosurgery and interventional neurology, including the treatments of stroke, brain aneurysms, and vascular malformations. In his strategic role in the new Sinai BioDesign Center, he assists faculty members in the development of novel devices and technologies. The center already has over 20 projects in development and is currently seeking new concepts.

 

Dr. Oxley is the founder and CEO of Synchron, a neural interface technology company. The internationally acclaimed stentrode device can record brain activity from within a blood vessel. In the intended application of the technology, the user’s thoughts are captured, decoded and passed wirelessly through the skin to enable control of digital devices that enable movement and speech restoration to previously paralyzed patients. A human clinical trial is close to commencement.

 

Dr. Oxley completed his PhD in neural engineering at the University of Melbourne, then completed both internal medicine and neurology residencies, as well as a stroke fellowship, in Australia. He performed his endovascular neurosurgery fellowship alongside Dr. Kellner at Mount Sinai under the direction of Drs. Mocco, Berenstein, Fifi, and De Leacy.

 

Dr. Oxley was published as first author in Nature Biotechnology for his research on “Minimally Invasive Endovascular Stent-Electrode Array for High-Fidelity, Chronic Recordings of cortical neural activity.” He has also published 30 internationally peer-reviewed articles that have accumulated 2080 citations with an H Index of 10.

 

Clinical Focus

 

Amyotrophic Lateral Sclerosis

Aneurysm Coiling

Brain Aneurysm

Brain Tumors

Carotid Artery Stenosis

Carotid Stenting

Cavernous Malformations

Cerebral Vasospasm

Dural Arteriovenous Fistula (DAVF)

Endovascular Embolization

 

Facial Arteriovenous Malformations

Facial Vascular Malformations

Hemangioblastoma

Mechanical Thrombectomy

Spinal Vascular Malformations

Stroke

Subarachnoid Hemorrhage

Vascular Malformations

Venous Sinus Thrombosis

 

Research Topics

 

Amyotrophic Lateral Sclerosis, Biomechanics/Bioengineering, Electrophysiology, Epilepsy, MRI, Motor Control, Muscular Dystrophy, Neuromodulation, Neurophysiology, Rehabilitation, Spinal Cord, Stroke

Education

 

MD, Monash University

 

Residency

Albury Hospital

 

Residency, Neurology

Alfred Hospital

 

Residency, Neurology

Royal Melbourne Hosp

 

Fellowship, Stroke Fellowship

Royal Melbourne Hospital

 

Fellowship, Vascular Neurology

Mount Sinai Hospital

 

Publications

https://plu.mx/mtsinai/u/toxley

 

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Oxley during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

 

Company Founder:

Synchron, Inc

Consulting:

Synchron, Inc

Employment:

Synchron, Inc

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

Synchron Inc

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose

Synchron, Inc

Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Synchron, Inc

Scientific Advisory Board:

Synchron, Inc

Service on Board of Directors: Service in a fiduciary capacity, such as an officer or director, for the following companies:

Synchron, Inc

 

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Anonymous ID: c40f6c Dec. 26, 2021, 8:55 a.m. No.117384   🗄️.is 🔗kun   >>7397 >>7473 >>7485

>>117371

>(could use a DIG)

Whole other fork below

 

Icahn School of Medicine at Mount Sinai. Department of Medical Education

https://archives.mssm.edu/icahn-school-of-medicine-at-mount-sinai-department-of-medical-education?sf_culture=en

 

Identity area

Type of entity

Corporate body

 

Authorized form of name

Icahn School of Medicine at Mount Sinai. Department of Medical Education

 

Description area

 

Dates of existence

1969-

 

History

 

This department was originally established as the Department of Laboratory Education in the new Mount Sinai School of Medicine. One of its initial focuses was the design and implementation of the multi-disciplinary laboratories for the medical students. In 1969, the name was broadened to the Department of Medical Education.

 

Mount Sinai School of Medicine held its first white coat ceremony in 1998. It is organized by the Department of Medical Education for first year students.

 

Control area

Authority record identifier

NA0266

---

https://icahn.mssm.edu/

https://icahn.mssm.edu/about/ait/levy-library

Anonymous ID: c40f6c Dec. 26, 2021, 9:30 a.m. No.117388   🗄️.is 🔗kun

>>117386

>Great dig!

o7

>whether it's really DARPA.

Thing that stands out from digging imho is Yoo Chinese, Sinai - Israeli, and NY + CA

Israel = NY

California = China

Wonder if this is like the Man in the High Tower...except rather than Japan getting the West China would have

And

Israel gets the East...

 

Stranger than fiction

Anonymous ID: c40f6c Dec. 26, 2021, 9:36 a.m. No.117391   🗄️.is 🔗kun   >>7402 >>7473 >>7485

>>117387

>sheep....as in Dolly the sheep? First clone. In the news then - GONE. Never heard another word.

Thought about that as well

 

Dolly: The Sheep That Changed The World, BBC2, review: A fitting tribute to a woolly icon

https://inews.co.uk/culture/television/dolly-the-sheep-that-changed-the-world-bbc2-review-documentary-cloning-1342884

 

Dolly the sheep, no relation to Shaun, was the world’s first cloned mammal and an overnight sensation in 1997.

 

International TV crews descended on the Roslin Institute near Edinburgh as news of the scientific breakthrough was leaked – one US network wanted to book Dolly for a chat show, which would have been interesting (or not).

 

And Dolly was apparently a diva. “She would literally fluff herself up for the cameras,” said embryologist Karen Walker, who also described how, lacking incubators to transport eggs and embryos, she would tuck them under her bra straps.

 

No wonder better-resourced American labs reacted with disbelief when Dolly was unveiled. This delightful BBC Scotland documentary was full of such characterful details, and any screenwriters looking for the next feel-good British (or Scottish) movie should look it up on iPlayer.

 

Meanwhile, an animal anaesthetist rather sheepishly (sorry) explained how Dolly’s name stuck after his throwaway remark about Dolly Parton and their animal’s creation from mammary gland cells. No doubt social media would have something to say about that today, but in 1997 the nearest Roslin came to being cancelled was by way of fire-bombing animal rights activists.

 

Misguided concerns over animal welfare aside, the film reminded us of the ethical worries about potential human cloning that fuelled TV discussion programmes at the time. But Dolly’s legacy – the hope for an era of “four-legged drug factories” to treat genetic diseases – is still largely unfulfilled, although it did boost the fruitful area of stem-cell research.

 

Dolly herself died young, overweight from being fed treats by her admirers, and now resides, stuffed by taxidermists, on a plinth at the National Museum of Scotland. But this colourful documentary was more a celebration of the painstaking brains behind this woolly icon.

Anonymous ID: c40f6c Dec. 26, 2021, 9:55 a.m. No.117393   🗄️.is 🔗kun   >>7473 >>7485

>>117387

dasting there is a ton of news on Dolly from Dec 8, think some docu came out

Dolly the Sheep scientists were bombarded with requests to clone dead people

The scientists behind Dolly the Sheep were harassed by grieving people desperate to see their loved ones again - begging them to use the same cloning method that created Dolly to bring humans back from the dead

https://www.mirror.co.uk/news/weird-news/dolly-sheep-scientists-were-bombarded-25647476

20:00, 8 Dec 2021

 

Contrary to popular belief, Dolly the Sheep was not actually the first animal to be cloned.

 

But the reason was she was so famous is probably because she was the first mammal to be cloned from an adult cell.

 

She's the subject of a documentary which airs on Wednesday on BBC Two, called Dolly: The Sheep that Changed the World.

 

Dolly was created in 1996 at the Roslin Institute in Midlothian, by a team led by Professor Ian Wilmut, as part of their research to find treatments for genetic disorders.

 

It was a controversial lab, with animal rights campaigners pointing out that genetically modifying animals and using them for scientific gain was causing them immense suffering.

 

Two fires broke out in separate animal research centres on the same day - with fire chiefs warning it might have been the work of activists.

 

Other critics refused to believe Dolly had really been cloned, while religious figures condemned the scientists for "playing God".

 

Dolly was the only surviving lamb from 277 cloning attempts and was created from an udder cell taken from a six-year-old Finn Dorset sheep.

 

The pioneering technique the Roslin team used involved transferring the nucleus of an adult cell into an unfertilised egg cell whose own nucleus had been removed.

 

An electric shock stimulated the hybrid cell to begin dividing and generate an embryo which was then implanted into the womb of a surrogate mother.

 

The result was a newborn animal that was a genetic copy of the original cell donor.

 

She was named after country singer Dolly Parton, with Wilmut explaining at the time: "Dolly is derived from a mammary gland cell and we couldn't think of a more impressive pair of glands than Dolly Parton's." kek

 

It was an "off the cuff" joke - but the name stuck.

 

As the news of Dolly's successful creation spread, scientists at the lab were bombarded by requests from grieving people, desperate for their loved ones to be cloned and brought back from the dead.

 

Dr Ron James, former managing director of PPL Therapeutics, the firm that helped make Dolly, said: "We had a letter which said that a chap's girlfriend had died a couple of weeks before he was due to get married, and could we clone her?

 

"The answer is, theoretically it might be possible, but you're going to get a tiny baby that's going to be 18 or 20 years younger than your girlfriend was."

 

It would also potentially take hundreds of embryos to get one successful human clone, all of which would need to be carried by a surrogate who would know it was unlikely they would be able to carry to term.

 

Dolly was bred with a Welsh Mountain ram and produced six lambs in total - Bonnie, twins Sally and Rosie, and triplets Lucy, Darcy and Cotton.

 

But in late 2001, at the age of four, she developed arthritis and began to walk stiffly.

 

This was treated with anti-inflammatory drugs at first, but eventually Dolly was euthanised aged six when she also developed lung disease - living just half her expected lifespan.

 

It was commonly thought that the disease was due to her being cloned, but actually Roslin scientists insisted this wasn't the case - it was fairly common in sheep and other sheep in the same flock had died from the same affliction.

 

However, it particularly affects sheep who are kept indoors - and mega-star Dolly always slept indoors for security reasons.

 

After her death, Dolly's body was preserved via taxidermy and is currently on display at the National Museum of Scotland in Edinburgh.

Anonymous ID: c40f6c Dec. 26, 2021, 3:10 p.m. No.117444   🗄️.is 🔗kun   >>7448 >>7450

>>117402

>Did Dolly really die young from being fed treats?

>(Why didn't her handlers stop that?)

Wondered the same

>Or could it have been due to the cloning process?

^^ or something moar nefarious - dissection for further study/sacrifice/lamb chops

Anonymous ID: c40f6c Dec. 26, 2021, 3:14 p.m. No.117446   🗄️.is 🔗kun

>>117428

> good luck somewhere else

Pray that you are never in a position to need help.

Used to be that was how it was done before the Government took it over.

Ask a neighbor, fren, fam, and community.

Anonymous ID: c40f6c Dec. 26, 2021, 3:40 p.m. No.117453   🗄️.is 🔗kun   >>7456 >>7473 >>7485

Predictable. Young Father Who Got Joe Biden to Repeat “Let’s Go Brandon!” Is Now Getting Death Threats from Angry Leftists

 

https://www.thegatewaypundit.com/2021/12/predictable-young-father-got-joe-biden-repeat-go-brandon-now-getting-death-threats-angry-leftists/

Anonymous ID: c40f6c Dec. 26, 2021, 4:51 p.m. No.117457   🗄️.is 🔗kun   >>7458

>>117456

>Dey not even angry at him, angry at life. He's just in the way.

Angry that he duped their an hero

 

>>117455

> then drove around to test all wheel drive w/summer ("all weather" - kek) tires

Had considered looking at how AWD does, but old skool. Like 4wd, prefer with front and rear lockers.

Anonymous ID: c40f6c Dec. 26, 2021, 5:23 p.m. No.117460   🗄️.is 🔗kun   >>7462 >>7465

>>117458

>flat-footed, no style

^^This

 

>Had a '69 w/4WD

Thinking about going back to similar style time frame, something that can be repaired offroad 70's mebbe. Had a 2006 Jeep Wrangler Rubicon...was fun for several years

Anonymous ID: c40f6c Dec. 26, 2021, 5:24 p.m. No.117461   🗄️.is 🔗kun   >>7464 >>7473 >>7480 >>7485

Ep. 2658b - The Insurrection Occurred On 11.3, Jan 6 Details Emerge Exposing The [DS] Operation

 

https://rumble.com/vr7de5-ep.-2658b-the-insurrection-occurred-on-11.3-jan-6-details-emerge-exposing-t.html

Anonymous ID: c40f6c Dec. 26, 2021, 7:57 p.m. No.117471   🗄️.is 🔗kun   >>7472 >>7473 >>7485

8 Minutes in to Godfather III

 

"The Pope, the Holy Father himself, has this very day blessed Michael Corleone; an' you think you know better than the Pope?"

Dominic Abbandando (Michael's PR Advisor, son of Genco) to reporters

 

http://www.thegodfathertrilogy.com/gf3/gf3quots.html

Anonymous ID: c40f6c Dec. 26, 2021, 8:07 p.m. No.117472   🗄️.is 🔗kun   >>7473 >>7480 >>7481 >>7485

 

 

>>117471

Godfather III Transcript

http://www.thegodfathertrilogy.com/gf3/transcript/gf3transcript.html

 

<Mary Corleone walks over to Vincent.>

 

MARY

Hi Vincent. I remember you.

 

VINCENT

You remember me? From where?

 

MARY

From the last time we had a party together.

 

VINCENT

Did you come down to the club?

 

MARY

No, it was a wedding.

 

VINCENT

A wedding?

 

MARY

I was 8; and you were 15

 

VINCENT

Well I, I had a lot of girlfriends when I was 15.

 

MARY

'8 year olds?

 

VINCENT

Especially 8 year olds!

NOTE: The transcript gives the actual line the .srt file truncates to "Especially them"

Anonymous ID: c40f6c Dec. 26, 2021, 8:29 p.m. No.117481   🗄️.is 🔗kun   >>7482 >>7484 >>7485

 

 

>>117472

Godfather III

~26:00min

MICHAEL

So kill him. What has all this have to do with me?

 

VINCENT

Well, he’s going around behind your back saying fuck Michael Corleone all time. That’s it, see, that’s one thing it has to do with you.

 

(then, to Zasa)

Right? Say it to his face, one time say it to his face, one time!